Abviva Receives Canadian Patent Office Notice For Mammastatin Technology
Abviva, a biomedical company which develops and commercialises breast cancer-related applications of Mammastatin, has received notice from the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Jul 10
Abviva, a biomedical company which develops and commercialises breast cancer-related applications of Mammastatin, has received notice from the…
26 Jul 10
Maquet Cardiovascular has launched its Vasoview Hemopro 2 endoscopic vessel harvesting (EVH) system, which utilises Hemopro cut-and-seal technology…
26 Jul 10
Abviva, a biomedical company which develops and commercialises breast cancer-related applications of Mammastatin, has received notice from the…
26 Jul 10
Cardiac Science, a global provider of automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has introduced two…
26 Jul 10
Circle Biologics has introduced Autologous Platelet Concentrator Platform (APC) in regenerative medicine. The device platform incorporates both autologous…
26 Jul 10
Cardiac Science, a global provider of automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has introduced two…
26 Jul 10
Circle Biologics has introduced Autologous Platelet Concentrator Platform (APC) in regenerative medicine. The device platform incorporates both autologous…
25 Jul 10
Vermillion, a molecular diagnostics company, has been relocating its corporate headquarters from Fremont, California to Austin, Texas. The…
25 Jul 10
Boston Scientific Corporation has been planning to launch Neuroform EZ Stent System in US and European markets immediately.
25 Jul 10
Cepheid, a molecular diagnostics company, has reported revenues of $49.6m for the second quarter of 2010, an increase…